|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$8,623,105
|
N/A
|
National Cancer Institute
|
|
The role of Src kinase in estrogen receptor-positive breast cancer proliferation
|
1F31CA180740-01
|
$35,622
|
$35,622
|
Abdullah, Christopher
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
1K99CA172697-01
|
$158,535
|
$79,268
|
Acharyya, Swarnali
|
SLOAN-KETTERING INST CAN RES
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
1R01CA171651-01A1
|
$633,775
|
$633,775
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Exergaming Intervention and Breast Cancer Biomarkers in Black Women
|
5R21CA165067-02
|
$194,493
|
$194,493
|
ADAMS-CAMPBELL, LUCILE
|
GEORGETOWN UNIVERSITY
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-03
|
$1,113,511
|
$111,351
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS
|
1R01CA172623-01A1
|
$412,601
|
$412,601
|
AFT, REBECCA
|
WASHINGTON UNIVERSITY
|
|
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
|
1R01CA172119-01A1
|
$733,270
|
$733,270
|
Ahles, Tim
|
SLOAN-KETTERING INST CAN RES
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
$410
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
$4,800
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
5R01CA152312-03
|
$340,511
|
$340,511
|
AKTAS, BERTAL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Estrogen Receptor Alpha Proteostasis in Breast Cancer
|
5R01CA159578-03
|
$292,197
|
$292,197
|
Alarid, Elaine
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,539,189
|
$76,959
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$15,750
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-04
|
$705,220
|
$105,783
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Characterization of WWOX, the Cancer Gene Spanning FRA16D
|
5R01CA102444-09
|
$313,050
|
$313,050
|
Aldaz, C.
|
UT MD ANDERSON CANCER CTR
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
3R01CA148994-03S1
|
$72,598
|
$72,598
|
Alizad, Azra
|
MAYO CLINIC ROCHESTER
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
5R01CA148994-03
|
$395,520
|
$395,520
|
Alizad, Azra
|
MAYO CLINIC ROCHESTER
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-05
|
$505,646
|
$252,823
|
Allbritton, Nancy
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Interleukin-4 Drives Tumor-Associated Macrophage Polarization to Promote Tumor Gr
|
1F30CA173910-01A1
|
$32,738
|
$32,738
|
Allen, Steven
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Margin Detection using Infrared Spectroscopy and Plasmon Resonance
|
5R21CA167403-02
|
$151,050
|
$49,847
|
Allen, Heather
|
OHIO STATE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,156,216
|
$23,124
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-44S1
|
$116,998
|
$11,700
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-44
|
$2,308,335
|
$230,834
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Control of Apoptosis in Cancer by Survivin
|
5R01CA078810-16
|
$287,949
|
$287,949
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-06
|
$325,422
|
$107,389
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Invasive breast cancer with and without DCIS: Race, risk factors and outcomes
|
1R03CA171061-01A1
|
$84,965
|
$84,965
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
5P01CA151135-03
|
$3,511,955
|
$3,511,955
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
DNA Methylation: a Mechanism for Aggressive Breast Cancer in African-American Wom
|
5R01CA133264-04
|
$781,546
|
$781,546
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Genome-Wide Predictors of Treatment-Related Toxicities
|
5R01CA139426-03
|
$927,470
|
$927,470
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$477,407
|
$477,407
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$177,063
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Evaluating the role of Thrombospondin-1-CD47 mediated nitric oxide signaling in t
|
1F31CA174096-01A1
|
$28,498
|
$9,404
|
Amend, Sarah
|
WASHINGTON UNIVERSITY
|
|
Role of Splicing Factors in Breast Cancer
|
1K99CA178206-01
|
$107,088
|
$107,088
|
ANCZUKOW-CAMARDA, OLGA
|
COLD SPRING HARBOR LABORATORY
|
|
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases
|
5K23CA157728-03
|
$173,089
|
$173,089
|
Anders, Carey
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Biobehavioral responses to cancer
|
5K05CA098133-09
|
$160,410
|
$80,205
|
Andersen, Barbara
|
OHIO STATE UNIVERSITY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
1UM1CA173642-01
|
$1,894,768
|
$341,058
|
ANDERSON, GARNET
|
FRED HUTCHINSON CAN RES CTR
|
|
PI Signaling Role in Epithelial/Mesenchymal Transition
|
5R01CA104708-09
|
$271,088
|
$271,088
|
ANDERSON, RICHARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Is GLUT1 required for tumor growth and the Warburg Effect?
|
5R01CA138482-03
|
$170,919
|
$170,919
|
ANDERSON, STEVEN
|
UNIVERSITY OF COLORADO DENVER
|
|
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
|
5R01CA156661-04
|
$281,660
|
$281,660
|
Andreana, Peter
|
UNIVERSITY OF TOLEDO
|
|
Dissecting Tumor Heterogeneity by Analyzing Signaling Pathway Requirements.
|
5R01CA160514-02
|
$289,663
|
$289,663
|
Andrechek, Eran
|
MICHIGAN STATE UNIVERSITY
|
|
LEGACY: A cohort of youth in families from the Breast Cancer Family Registry
|
4R01CA138844-03
|
$361,633
|
$361,633
|
Andrulis, Irene
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
|
3R01CA169127-02S1
|
$41,074
|
$41,074
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
|
5R01CA169127-02
|
$281,847
|
$281,847
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-29
|
$638,503
|
$210,706
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$423,806
|
$211,903
|
Appella, Ettore
|
CCR (NCI)
|
|
Near-Infrared Fluorescent Choline Kinase Inhibitors for Cancer Imaging and Therap
|
1F31CA180328-01
|
$42,232
|
$42,232
|
Arlauckas, Sean
|
UNIVERSITY OF PENNSYLVANIA
|
|
Notch Signaling in Mammary Development and Tumorigenesis
|
5R01CA098402-11
|
$335,835
|
$335,835
|
ARTAVANIS-TSAKONAS, SPYRIDON
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
SPORE in Breast Cancer
|
2P50CA098131-11
|
$2,150,500
|
$2,150,500
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY MED CTR
|
|
Erbb2 targeted antitumor strategies in breast cancer
|
5R01CA080195-13
|
$293,808
|
$293,808
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY MED CTR
|
Total relevant funding to Breast for this search: $559,172,103
|